Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML.,
Li, Sheng, Chen Xiaowen, Wang Jiahui, Meydan Cem, Glass Jacob L., Shih Alan H., Delwel Ruud, Levine Ross L., Mason Christopher E., and Melnick Ari M.
, Cancer Discov, 2020 Dec, Volume 10, Issue 12, p.1934-1949, (2020)
Targeted detection and quantitation of histone modifications from 1,000 cells.,
Abshiru, Nebiyu A., Sikora Jacek W., Camarillo Jeannie M., Morris Juliette A., Compton Philip D., Lee Tak, Neelamraju Yaseswini, Haddox Samuel, Sheridan Caroline, Carroll Martin, et al.
, PLoS One, 2020, Volume 15, Issue 10, p.e0240829, (2020)
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.,
Venturutti, Leandro, Teater Matt, Zhai Andrew, Chadburn Amy, Babiker Leena, Kim Daleum, Béguelin Wendy, Lee Tak C., Kim Youngjun, Chin Christopher R., et al.
, Cell, 2020 Jul 23, Volume 182, Issue 2, p.297-316.e27, (2020)
The therapeutic landscape for cells engineered with chimeric antigen receptors.,
MacKay, Matthew, Afshinnekoo Ebrahim, Rub Jonathan, Hassan Ciaran, Khunte Mihir, Baskaran Nithyashri, Owens Bryan, Liu Lauren, Roboz Gail J., Guzman Monica L., et al.
, Nat Biotechnol, 2020 Feb, Volume 38, Issue 2, p.233-244, (2020)
Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage.,
Chu, Chi-Shuen, Hellmuth Johannes C., Singh Rajat, Ying Hsia-Yuan, Skrabanek Lucy, Teater Matthew R., Doane Ashley S., Elemento Olivier, Melnick Ari M., and Roeder Robert G.
, Mol Cell, 2020 Dec 03, Volume 80, Issue 5, p.845-861.e10, (2020)
